In terms of regulation 30 of the SEBI (LODR) Regulations, 2015, Jagsonpal Pharmaceuticals has informed it enclosed a copy of the Press Release issued by the Company titled ‘Jagsonpal Launches MemUp: India's First Bioidentical Hormone Replacement Therapy in a Single Pill’.
The above information is a part of company’s filings submitted to BSE.